A case of septicaemic anthrax in an intravenous drug user.
BACKGROUND
In 2000, Ringertz et al described the first case of systemic anthrax caused by injecting heroin contaminated with anthrax. In 2008, there were 574 drug related deaths in Scotland, of which 336 were associated with heroin and or morphine. We report a rare case of septicaemic anthrax caused by injecting heroin contaminated with anthrax in Scotland.


METHODS
A 32 year old intravenous drug user (IVDU), presented with a 12 hour history of increasing purulent discharge from a chronic sinus in his left groin. He had a tachycardia, pyrexia, leukocytosis and an elevated C-reactive protein (CRP). He was treated with Vancomycin, Clindamycin, Ciprofloxacin, Gentamicin and Metronidazole. Blood cultures grew Bacillus anthracis within 24 hours of presentation. He had a computed tomography (CT) scan and magnetic resonance imagining (MRI) of his abdomen, pelvis and thighs performed. These showed inflammatory change relating to the iliopsoas and an area of necrosis in the adductor magnus.He underwent an exploration of his left thigh. This revealed chronically indurated subcutaneous tissues with no evidence of a collection or necrotic muscle. Treatment with Vancomycin, Ciprofloxacin and Clindamycin continued for 14 days. Negative Pressure Wound Therapy (NPWT) device was applied utilising the Venturi™ wound sealing kit. Following 4 weeks of treatment, the wound dimensions had reduced by 77%.


CONCLUSIONS
Although systemic anthrax infection is rare, it should be considered when faced with severe cutaneous infection in IVDU patients. This case shows that patients with significant bacteraemia may present with no signs of haemodynamic compromise. Prompt recognition and treatment with high dose IV antimicrobial therapy increases the likelihood of survival. The use of simple wound therapy adjuncts such as NPWT can give excellent wound healing results.
Department of Surgical Gastroenterology, Gartnavel General Hospital, Glasgow, UK. arfonpowell@doctors.org.uk
Arfon G M T
AG
Powell
Joseph E M
JE
Crozier
Heather
H
Hodgson
David J
DJ
Galloway
D000328:Adult; D000881:Anthrax / Q000209:etiology* / Q000382:microbiology; D001408:Bacillus anthracis / Q000302:isolation & purification / Q000502:physiology; D016470:Bacteremia / Q000209:etiology* / Q000382:microbiology; D004340:Drug Contamination; D055030:Drug Users; D003932:Heroin / Q000008:administration & dosage / Q000009:adverse effects*; D006801:Humans; D008297:Male; D015819:Substance Abuse, Intravenous / Q000150:complications*
D003932:Heroin
J Infect Public Health. 2010;3(3):98-105
20869669
Addiction. 1994 Oct;89(10):1299-308
7804091
Addiction. 1997 Apr;92(4):419-27
9177063
Wounds. 2009 Nov;21(11):302-9
25902776
JAMA. 1999 May 12;281(18):1735-45
10328075
J Med Microbiol. 2002 Nov;51(11):971-977
12448681
N Engl J Med. 2001 Nov 29;345(22):1607-10
11704685
Postgrad Med J. 2006 Nov;82(973):754-6
17099096
Emerg Infect Dis. 2001 Nov-Dec;7(6):933-44
11747719
Ann Intern Med. 2006 Feb 21;144(4):270-80
16490913
Euro Surveill. 2010 Jan 14;15(2):
20085694
Curr Clin Top Infect Dis. 2000;20:335-49
10943532
N Engl J Med. 2001 Nov 29;345(22):1621-6
11704686
J Infect Dis. 1974 Mar;129(3):327-9
4361247
Lancet. 2000 Nov 4;356(9241):1574-5
11075776
N Engl J Med. 1999 Sep 9;341(11):815-26
10477781